Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

@article{Cohen2012AdverseEO,
  title={Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.},
  author={David Jacques Cohen and Olivier Bonnot and Nicolas Bodeau and Ang{\`e}le Consoli and Claudine Laurent},
  journal={Journal of clinical psychopharmacology},
  year={2012},
  volume={32 3},
  pages={309-16}
}
In adults, second-generation antipsychotics (SGAs) have a low frequency of extrapyramidal syndrome (EPS) and a moderate frequency of metabolic adverse effects. Here we aimed to assess short-term adverse effects of SGAs in children and adolescents. We searched for relevant studies in MEDLINE and EMBASE (1996-2010), Food and Drug Administration and European Medicines Agency clinical trial registries, and reference lists of review articles. We found 41 were short-term (3-12 weeks) controlled… CONTINUE READING
32 Citations
60 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Surveillance of metabolic syndrome , hyperprolactinemia and cardiac side effects in children and adolescent treated with antipsychotic . Actuality and recommendations

  • L Governale, H Mehta
  • Neuropsychiatr Enfance Adolesc
  • 2010

Similar Papers

Loading similar papers…